相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
Henry G. Bone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial
Felicia Cosman et al.
MAYO CLINIC PROCEEDINGS (2017)
Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture
Jessica Weaver et al.
Journal of Managed Care & Specialty Pharmacy (2017)
A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture
Claire E. O'Hanlon et al.
CLINICAL THERAPEUTICS (2017)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2016
Pauline M. Camacho et al.
ENDOCRINE PRACTICE (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Advantages and disadvantages of discrete-event simulation for health economic analyses
J. Jaime Caro et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)
Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States
Lung-I Cheng et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2015)
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
Nicole C. Wright et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Intervention thresholds for denosumab in the UK using a FRAXA®-based cost-effectiveness analysis
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2013)
The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
Daniel R. Murphy et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
Roland Baron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Modeling Using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
Jonathan Karnon et al.
MEDICAL DECISION MAKING (2012)
Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension
Joanne LaFleur et al.
HEART (2011)
Cost-Effectiveness of Oral Bisphosphonates for Osteoporosis at Different Ages and Levels of Life Expectancy
Annalise N. Pham et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Updated fracture incidence rates for the US version of FRAXA (R)
B. Ettinger et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?
Jaime J. Caro et al.
VALUE IN HEALTH (2010)
Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis
Fredrik Borgström et al.
JOURNAL OF MEDICAL ECONOMICS (2010)
Incidence and Mortality of Hip Fractures in the United States
Carmen A. Brauer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Excess mortality following hip fracture: a systematic epidemiological review
B. Abrahamsen et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The cost-effectiveness of therapy with Teriparatide and alendronate in women with severe osteoporosis
Hau Liu et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women
J Lundkvist et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment
R Prince et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
JT Schousboe et al.
ANNALS OF INTERNAL MEDICINE (2005)
Epidemiology of osteoporotic fractures
Olof Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2005)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
R Lindsay et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study
CL Leibson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
A systematic review of health state utility values for osteoporosis-related conditions
JE Brazier et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions
ANA Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
CM Klotzbuecher et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
